Your session is about to expire
← Back to Search
Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors
N/A
Recruiting
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled oncological treatments completed
Stress or mixed urinary incontinence with a frequency of at least three urinary leakage per
Must not have
Pelvic floor rehabilitation in the last year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 2-week post-treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a certain type of physical therapy can help treat urinary incontinence in cancer survivors.
Who is the study for?
This trial is for women who have survived gynecological cancers like endometrial or cervical cancer and are now experiencing urinary incontinence at least three times a week. They should be done with their scheduled cancer treatments but haven't had pelvic floor rehab in the past year, and don't have other conditions that could affect the study.
What is being tested?
The study is testing physiotherapy as a treatment for urinary incontinence against standard care given to survivors of gynecological cancers. It's a pilot study meant to set up for a larger future trial by checking how feasible this approach is.
What are the potential side effects?
Since this trial involves physiotherapy, side effects might include temporary soreness or muscle fatigue from exercises. Unlike drug trials, there's less risk of systemic side effects since it's non-invasive.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have finished all my planned cancer treatments.
Select...
I experience urinary leakage at least three times a week.
Select...
I have had cancer in my reproductive organs.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have undergone pelvic floor rehabilitation in the past year.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 2-week post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 2-week post-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence rates
Retention rate
Secondary study objectives
Change from baseline in number of urinary leaks
Change from baseline in pelvic floor muscle function
Change from baseline in pelvic floor muscle morphometry
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PhysiotherapyExperimental Treatment1 Intervention
12-weekly physiotherapy treatment sessions.
Group II: Standard usual careActive Control1 Intervention
Participants will be asked to continue the usual care established during the regular follow-up with their medical doctor for 12 weeks.
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)OTHER
380 Previous Clinical Trials
131,545 Total Patients Enrolled
Université de SherbrookeLead Sponsor
307 Previous Clinical Trials
77,580 Total Patients Enrolled
3 Trials studying Urinary Incontinence
198 Patients Enrolled for Urinary Incontinence
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
62 Previous Clinical Trials
33,510 Total Patients Enrolled
2 Trials studying Urinary Incontinence
78 Patients Enrolled for Urinary Incontinence
Institut Universitaire de Gériatrie de MontréalOTHER
2 Previous Clinical Trials
88 Total Patients Enrolled
Jewish General HospitalOTHER
142 Previous Clinical Trials
279,607 Total Patients Enrolled
2 Trials studying Urinary Incontinence
194 Patients Enrolled for Urinary Incontinence
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Other health issues that might make it hard to evaluate the study results.I have finished all my planned cancer treatments.I have undergone pelvic floor rehabilitation in the past year.I experience urinary leakage at least three times a week.I have had cancer in my reproductive organs.
Research Study Groups:
This trial has the following groups:- Group 1: Physiotherapy
- Group 2: Standard usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.